FDA crackdown on Indian drug firms no witch hunt

India's generic drug industry can't grudge the US Food and Drug Administration (FDA) for the penal actions it has taken against some of its poster boys recently. This is because the FDA apparently maintains a high degree of objectivity in its actions. The FDA's meticulousness and stringency of parameters, though of a much higher order compared with Indian authorities', allows for giving a proper hearing to companies found to violate its norms and a system of graded penalties, irrespective of nationality.

Read Full Story>>